Crispr Therapeutics shares owned by Valeo Financial Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Valeo Financial Advisors
from 13F filings
Historical chart of Valeo Financial Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Valeo Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Valeo Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $639k | 9.4k | 68.16 |
| 2023-12-31 | $618k | 9.9k | 62.60 |
| 2023-09-30 | $473k | 10k | 45.39 |
| 2023-06-30 | $393k | 7.0k | 56.14 |
| 2023-03-31 | $423k | 9.4k | 45.23 |
| 2022-12-31 | $286k | 7.0k | 40.65 |
| 2022-09-30 | $441k | 6.7k | 65.36 |
| 2022-06-30 | $580k | 9.5k | 60.75 |
| 2022-03-31 | $559k | 8.9k | 62.75 |
| 2021-12-31 | $565k | 7.5k | 75.76 |
| 2021-09-30 | $676k | 6.0k | 111.96 |
| 2021-06-30 | $916k | 5.7k | 161.95 |
| 2021-03-31 | $690k | 5.7k | 121.89 |
| 2020-12-31 | $572k | 3.7k | 153.06 |
| 2020-09-30 | $326k | 3.9k | 83.55 |
| 2020-06-30 | $284k | 3.9k | 73.40 |
| 2020-03-31 | $37k | 803 | 46.08 |
| 2019-12-31 | $46k | 750 | 61.33 |
| 2019-09-30 | $26k | 640 | 40.62 |
| 2019-06-30 | $34k | 725 | 46.90 |
| 2019-03-31 | $26k | 725 | 35.86 |
| 2018-12-31 | $12k | 423 | 28.37 |
| 2018-09-30 | $12k | 379 | 31.66 |
| 2018-06-30 | $4.0k | 85 | 47.06 |
| 2018-03-31 | $5.0k | 105 | 47.62 |
| 2017-12-31 | $3.0k | 130 | 23.08 |
| 2017-09-30 | $1.0k | 70 | 14.29 |